Trial intelligence / Profile preview

Morphine versus ketorolac in low back pain

NCT02782286Phase 4Unknown

Start
May 2016
Primary completion
Sep 2016
Modality
Small Molecules
01

Overview

Phase 4, randomised, double-blind trial of morphine and ketorolac in low back pain (LBP). Primary endpoint: Reducing the grade of pain at 30 minutes. Status: unknown.

02

Drugs

morphineketorolac
03

Conditions

low back pain (LBP)

Beyond the preview

Go deeper on NCT02782286.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02782286.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call